Bengaluru: Abbott Laboratories and DexCom said on Monday they have reached an agreement to settle all patent disputes between them related to continuous glucose monitoring devices.
The agreement will dismiss all pending cases in courts and patent offices worldwide, along with a provision preventing legal action between the companies for patent and appearance disputes for the next 10 years.
Abbott and DexCom have accused each other of infringing certain patents multiple times over the years.
As part of the agreement, Abbott also granted DexCom a worldwide, royalty-free, non-exclusive, fully paid-up license to certain patents and applications.
There are no financial payments associated with the settlement from either company. (Reporting by Puyaan Singh in Bengaluru; Editing by Vijay Kishore)
